Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Psoriatic Arthritis Treatment Market

Psoriatic Arthritis Treatment Market Size

Report ID: GMI9864
Published Date: Jun 2024
Report Format: PDF

Download Free Sample

Psoriatic Arthritis Treatment Market Size

Psoriatic Arthritis Treatment Market size was valued at USD 10.2 billion in 2023 and is estimated to grow at 9.7% CAGR from 2024 to 2032. The market has seen considerable growth due to the increasing prevalence of psoriatic arthritis globally.

Psoriatic Arthritis Treatment Market

To get key market trends

Download Free Sample

According to data reported by the National Psoriasis Foundation, around 125 million people worldwide (2 to 3 percent of the total population) have psoriasis, and an estimated 30 percent of these individuals develop psoriatic arthritis. This significant patient population tends to drive the demand for advanced treatment options, thereby boosting market growth. Furthermore, advancements in biologic drugs and personalized medicine, alongside growing awareness about early diagnosis and treatment are significantly contributing to market expansion.

Psoriatic Arthritis Treatment Market Report Attributes
Report Attribute	Details
Base Year:	2023
Psoriatic Arthritis Treatment Market Size in 2023:	USD 10.2 Billion
Forecast Period:	2024 - 2032
Forecast Period 2024 - 2032 CAGR:	9.7%
2032 Value Projection:	USD 23.3 Billion
Historical Data for:	2021 – 2023
No. of Pages:	160
Tables, Charts & Figures:	277
Segments covered:	Drug Type, Route of Administration, Medication Type, Age Group, Distribution Channel, and Region
Growth Drivers:	Increasing prevalence of psoriatic arthritis Expanding R&D funding and activities Growing awareness and diagnosis Improved diagnostic technologies
Pitfalls & Challenges:	Side effects and adverse reactions Regulatory challenges

Learn more about the key segments shaping this market

Download Free Sample

Psoriatic arthritis treatment involves medical interventions aimed at managing the symptoms and progression of psoriatic arthritis, a chronic inflammatory disease affecting joints and skin. Treatments include nonsteroidal anti-inflammatory drugs (NSAIDs), disease-modifying antirheumatic drugs (DMARDs), biologic agents targeting specific immune pathways, and corticosteroids to reduce inflammation.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global psoriatic arthritis treatment industry was valued at USD 10.2 billion in 2023 and is anticipated to register 9.7% CAGR between 2024 and 2032 due to increasing prevalence of psoriatic arthritis and growing awareness and diagnosis.

The injectable segment in the market held 57.7% revenue share in 2023 due to precise dosing, direct bloodstream delivery, and established efficacy.

Asia Pacific psoriatic arthritis treatment market size is expected to record 10.2% CAGR between 2024 and 2032 due to expanding population, product approvals coupled with increasing awareness and diagnosis rates of psoriatic arthritis.

Abbvie Inc., Amgen Inc., Biogen, Bristol-Myers Squibb Company, Eli Lilly and Company, Fujifilm Kyowa Kirin Biologics Co., Ltd., Janssen Pharmaceutical Companies (Johnson and Johnson), Merck KGA, and Novartis AG, among others.